A field guide to BPC-157The criteria
PRODUCT / CARE / COMMITMENT
Open the provider file

Research explained

BPC-157 after mesenteric-vein obstruction

Short-term rat collateral recruitment is not a demonstrated treatment for human mesenteric thrombosis.

On this page

Read the experiment

The finding and its boundary

The report describes collateral-flow changes and attenuation of vascular and organ disturbances. Short-term rat collateral recruitment is not a demonstrated treatment for human mesenteric thrombosis.

Complex Syndrome of the Complete Occlusion of the End of the Superior Mesenteric Vein, Opposed with the Stable Gastric Pentadecapeptide BPC 157 in Rats.

Experiment
Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
Study system
Rats with permanent ligation of the superior mesenteric vein end
Measured outcome
Venography, pressure, ECG, thrombosis and tissue injury
Reported result
The report describes collateral-flow changes and attenuation of vascular and organ disturbances.
What this cannot establish
Short-term rat collateral recruitment is not a demonstrated treatment for human mesenteric thrombosis.
Open the primary paper

What was actually tested

Rats with permanent ligation of the superior mesenteric vein end. The investigators measured venography, pressure, ECG, thrombosis and tissue injury. The report describes collateral-flow changes and attenuation of vascular and organ disturbances.

The detail that changes the takeaway

A vein draining the bowel is anatomically different from the artery supplying it. Readers should not merge the two papers into a single vascular finding. The location of the ligature determines which pressures and bypass routes are relevant and what questions a later study must address.

How far the result travels

Short-term rat collateral recruitment is not a demonstrated treatment for human mesenteric thrombosis.

A useful comparison

BPC-157 after mesenteric-artery obstruction examines collateral circulation, pressure, thrombosis and organ lesions. Here, the measured endpoint was venography, pressure, ECG, thrombosis and tissue injury. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the BPC-157 and experimental pancreatitis: many organ measurements are still one rat model appraisal.

References & product documents

The evidence and service information used here.

  1. BPC-157 after mesenteric-vein obstruction — original indexed research

Next in the field guide

The provider file
  1. 01

    BPC-157 after mesenteric-artery obstruction

    The experiment does not establish clinical management of acute bowel ischemia.

  2. 02

    BPC-157 and experimental pancreatitis: many organ measurements are still one rat model

    The 2022 paper examined bile-duct ligation and associated vascular disturbances. It did not test human pancreatitis care.

  3. 03

    BPC-157 and an established fistula in rats: delayed treatment is still preclinical

    A 2021 experiment tested a surgically created urinary fistula after it had formed. It did not compare human surgical and peptide treatment strategies.

Before you leave

One more option to compare.

Another provider review

We may earn a commission from qualifying provider referrals. Affiliate placements are labeled Partner. How we are funded

Continue to your choiceRead another review